Loteprednol etabonate
Anti-inflammatory · Rx
RxAnti-inflammatorySteroid Pink cap
| Strength | 0.2%, 0.38%, 0.5%, 1% |
|---|---|
| Typical quantity | 5-15 mL bottle (generic Lotemax available) |
| Cash cost / month | Moderate · ~$20-100 |
| Drug class | Corticosteroid, ester |
| Mechanism of action | Ester (C-20) corticosteroid designed for rapid inactivation after acting locally; lower propensity for IOP rise and cataract than ketone steroids. |
| Indication / reason for use | Post-operative inflammation (Lotemax SM, Inveltys), inflammatory ocular surface disease, giant papillary conjunctivitis, seasonal allergic conjunctivitis (Alrex 0.2%), mild-moderate uveitis. |
| Usual adult dosing | Lotemax 0.5% QID; Lotemax SM TID; Inveltys BID; Alrex QID. Shake gel/suspension. |
| Preservative | BAK 0.003%; gel formulations use lower/absent BAK |
| Contact lenses | Do not wear lenses during treatment of ocular inflammation. |
| Common / important adverse effects | Lower IOP-spike risk than prednisolone but still possible with prolonged use; blurred vision, burning. |
| Contraindications & cautions | Active epithelial herpes simplex, fungal, or mycobacterial infection. |
| Pregnancy / lactation | Limited data; low systemic exposure. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Lotemax 0.5%, Lotemax SM 0.38%, Inveltys 1%, Alrex 0.2% |
| Practice notes | A reasonable choice for known steroid responders or when longer courses are anticipated, still monitor IOP. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.